| Literature DB >> 33833465 |
Alexander N Gorelick1,2, Minsoo Kim1, Walid K Chatila1,2,3, Konnor La4, A Ari Hakimi5, Michael F Berger3,6, Barry S Taylor1,2,3, Payam A Gammage7,8, Ed Reznik9,10,11.
Abstract
Mitochondrial DNA (mtDNA) encodes protein subunits and translational machinery required for oxidative phosphorylation (OXPHOS). Using repurposed whole-exome sequencing data, in the present study we demonstrate that pathogenic mtDNA mutations arise in tumours at a rate comparable to those in the most common cancer driver genes. We identify OXPHOS complexes as critical determinants shaping somatic mtDNA mutation patterns across tumour lineages. Loss-of-function mutations accumulate at an elevated rate specifically in complex I and often arise at specific homopolymeric hotspots. In contrast, complex V is depleted of all non-synonymous mutations, suggesting that impairment of ATP synthesis and mitochondrial membrane potential dissipation are under negative selection. Common truncating mutations and rarer missense alleles are both associated with a pan-lineage transcriptional programme, even in cancer types where mtDNA mutations are comparatively rare. Pathogenic mutations of mtDNA are associated with substantial increases in overall survival of colorectal cancer patients, demonstrating a clear functional relationship between genotype and phenotype. The mitochondrial genome is therefore frequently and functionally disrupted across many cancers, with major implications for patient stratification, prognosis and therapeutic development.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33833465 PMCID: PMC9304985 DOI: 10.1038/s42255-021-00378-8
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812